<DOC>
	<DOCNO>NCT00403780</DOCNO>
	<brief_summary>The hypothesis behind trial concept Pregabalin effective reduce pain rest low limb ischemia , study evaluates active treatment placebo add regular pain regimen patient .</brief_summary>
	<brief_title>Randomized Study Pregabalin Pain Reduction Patients With Rest Pain Lower Limb Ischemia</brief_title>
	<detailed_description>Critical limb ischemia ( CLI ) end stage peripheral arterial disease legs consequence deteriorate blood flow supply low limb . The clinical definition CLI include peripheral arterial disease recurrent rest pain least two week without ulcer gangrene . In patient amenable revascularization - around 35 % - amputation palliative conservative care remain option . Pain control vital part treatment patient . Besides principal conservative treatment , also patient undergo revascularization experience severe pain work surgery . Experimental data indicate pain CLI multimodal large extent neuropathic . Still , current therapy mostly base opioid treatment , clinically often affect pain moderately . The dos require influence pain also associate severe side effect . Accordingly , great need improve pain control rather common disease CLI . comparison : pregabalin 600mg daily addition regular pain regimen compare placebo regular pain regimen .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Rest pain , gangrene ulcer locate patella duration least two week ( either one criterion sufficient ) . One measurement : Ankle blood pressure ( ABP ) &lt; 70 mm Hg , toe blood pressure ( TBP ) &lt; 50 , TcPO2 &lt; 45 mm Hg , ankle/brachial pressure index &lt; 0.7 ( either one criterion sufficient ) . Informed consent obtain Age &lt; 55 year Women childbearing potential Patients already medicate Pregabalin Gabapentin Creatinine clearance &lt; 30ml/min Amputation necessary within two week Revascularization necessary within two week ( open vascular surgery endovascular ) A medical history clear dizziness NYHA class IV heart failure Known hypotension , systolic arm blood pressure &lt; 120 mm Hg ( two consecutive measurement patient lie supine ) Simultaneous previous ( within 30 day prior study entry participation clinical study use experimental drug device Mental condition make subject unable understand concept risk study Known allergy pregabalin</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Critical limb ischemia</keyword>
	<keyword>Pain control</keyword>
	<keyword>Rest pain low limb ischemia</keyword>
	<keyword>pregabalin</keyword>
	<keyword>randomize control study</keyword>
	<keyword>Ischemia , therapy</keyword>
	<keyword>Lower extremity , blood supply</keyword>
	<keyword>Pain , prevention &amp; control</keyword>
	<keyword>Pain , therapy</keyword>
</DOC>